About the Arizona PMP
The Arizona Controlled Substances Prescription Monitoring Program (PMP) is managed by the Arizona State Board of Pharmacy. Under the guidance of Doug Skvarla, RPh, Program Director, and governed by A.R.S. § 36-2602, the PMP team provides the State of Arizona with a central database to track the dispensing of Schedule II, III, IV, and V controlled substances in the state. The statutes surrounding the PMP include A.R.S. § 36-2601 through 36-2610.
User Access & Data Management - Authorized persons may request information from the PMP to assist them in treating patients and identifying and deterring drug diversion, consistent with A.R.S. § 36-2604. The PMP administrators vet applicants and grant access to individual licensed health professionals able to prescribe or dispense Schedules II through V controlled substances. Examples of health professionals with access include physicians, dentists, pharmacists, and more. The PMP Administrators also assist users with account information management and general questions.
Release of PMP Data - Under A.R.S. § 36-2604, the PMP may also release data collected by the program to the following: an individual who requests the individual's prescription monitoring information, a medical practitioner regulatory board, a law enforcement or criminal justice agency (local, state or federal), a health care insurer, a person who is serving a lawful order of a court of competent jurisdiction, or a county medical examiner who is directing an investigation into the circumstances surrounding a death. Different statutory requirements must be met to release PMP data to each requestor stated above. The PMP administrators protect the confidentiality and security of the data through the collection and storage process as well as through the transmission of requested reports.
PMP Integration with Electronic Health Records - The ASBP helps fund integration allowing healthcare entities large and small to connect to the PMP through their current electronic health record system or pharmacy management system and the PMP Gateway (integrated product). This makes connecting to the PMP more efficient and easier to use because the user is not required to log in to the web portal. Through various methods of education and outreach efforts, the PMP team works toward the goal of integrating every interested and eligible entity in the state of Arizona and tracks the progress of integration efforts on a public spreadsheet located on the PMP website’s integration page.
Compliance - During the August 2021 PMP Task Force meeting, task force members agreed that the PMP staff should begin measuring compliance regarding PMP registration, data reporting, and usage requirements. The PMP compliance team works closely with data submitters, medical professionals, and licensing boards to ensure various compliance requirements are met under Arizona statutes.
Community Outreach & Education - The PMP is dedicated to providing educational resources to the public regarding the PMP’s uses and benefits through various learning opportunities. The PMP’s team represents the program at many events across the State of Arizona including, but not limited to: opioid seminars, law enforcement training events, and new medical resident orientations. The PMP has many helpful tools including training videos and FAQs built into the PMP website to further assist those seeking information about the program.
Public Facing Dashboard & Data Analysis - The PMP maintains a public-facing dashboard, which can be filtered by county and year, that provides information on such areas as:
- Number of prescriptions and dosage units dispensed in Arizona
- Overlapping opioid and benzodiazepine usage
- Prescription count by demographics
- The PMP team collaborates with other public health agencies and academic institutions to provide data for their dashboards, presentations, studies, and reports.
Interstate Data Sharing - Arizona currently shares data nationwide with 46 states, as well as Puerto Rico and the Military Health System. Interstate data collaborative efforts have increased the availability of valuable information for medical professionals to assist them in making the best healthcare decisions for their patients and deter drug diversion. Interstate data availability varies based on each state’s statutory limitations.